This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Olin (OLN) Q2 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Olin (OLN) beats on second-quarter earnings but misses on revenues due to lower volumes in its chemical businesses.
Olin (OLN) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Olin (OLN) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Olin (OLN) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of 8.65% and 7.97%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Olin (OLN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Olin (OLN) Revises Q2 Outlook, Implements Restructuring
by Zacks Equity Research
Olin (OLN) revises second-quarter outlook, citing an extended plant turnaround and lower market participation, while implementing strategic restructuring to enhance financial resilience.
Strength Seen in Chemours (CC): Can Its 24.1% Jump Turn into More Strength?
by Zacks Equity Research
Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Olin's (OLN) Earnings and Revenues Miss Estimates in Q1
by Zacks Equity Research
Lower volumes in its chemical businesses hurt Olin's (OLN) Q1 top line.
Olin (OLN) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of -9.38% and 6.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
FMC (FMC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
FMC (FMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Olin (OLN) Q1 Earnings Expected to Decline
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Olin (OLN) to Close Epoxy Facilities in Restructuring Program
by Zacks Equity Research
Olin (OLN) decides to cease operations at its epoxy facilities as part of an ongoing restructuring program in response to lower demand for its epoxy products.
Company News for Jan 30, 2023
by Zacks Equity Research
Companies In The News Are: CVX, CHTR, INTC, OLN.
Olin's (OLN) Earnings Beat Estimates in Q4, Revenues Lag
by Zacks Equity Research
Lower volumes from chemical businesses hurt Olin's (OLN) top line in the fourth quarter.
Olin (OLN) Tops Q4 Earnings Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of 0.70% and 2.37%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Q4 Earnings Slated on Jan 26: DOW, EMN & OLN
by Anindya Barman
Chemical companies' Q4 results are likely to have been driven by stable end-market demand and the benefits of strategic actions amid headwinds from input and energy cost inflation. Let's see how DOW, EMN and OLN are poised ahead of their earnings releases.
Why Olin (OLN) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Analysts Estimate Olin (OLN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Olin (OLN) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Olin (OLN) Up 10.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Olin (OLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Olin's (OLN) Earnings Surpass Estimates in Q3, Sales Lag
by Zacks Equity Research
Olin (OLN) sees higher sales in its Chlor Alkali Products and Vinyls unit in Q3 on the back of higher pricing.
Olin (OLN) Q3 Earnings Beat Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of 17.20% and 2.64%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Eastman Chemical (EMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Olin (OLN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is FMC (FMC) Down 0.9% Since Last Earnings Report?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should JPMorgan Diversified Return U.S. Equity ETF (JPUS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JPUS